Registration - In-house Corporation

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Registration Information

In-house Corporation name: sanofi-aventis Canada Inc.
Previous in-house corporation names
Responsible Officer Name: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)
Responsible Officer Change History
Initial registration start date: 2005-08-22
Registration status: Active
Registration Number: 951483-5180

Associated Communications

Total Number of Communication Reports: 121

Monthly communication reports in the last 6 months: 0

Version 15 of 41 (2010-12-09 to 2011-01-13)

Registration versions:

Version 15 of 41 (2010-12-09 to 2011-01-13)

Lobbying Information

Subject Matters

Aboriginal Affairs
Health
Industry
Intellectual Property
Internal Trade
International Relations
International Trade
Justice and Law Enforcement
Regional Development
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Policy or Program Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with respect to strengthening the safety of drug products/therapeutic products in the Food and Drug Regulations
Patent Act as it relates to the regulation of intellectual property for therapeutic products

Legislative Proposal, Bill or Resolution, Regulation

Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products

Policies or Program

Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Health Canada Blueprint for Renewal: Modernizing Regulatory System for Health Products and Food (formerly Bill C-51)
Policy or program: Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy

Policies or Program, Regulation

Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees

Regulation

Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.

Communication Techniques

Written communication
Oral communication
Grass-roots communication
Meetings, presentations and telephone communication

Government Institutions

Aboriginal Affairs and Northern Development Canada
Atlantic Canada Opportunities Agency (ACOA)
Federal Office of Regional Development – Quebec (FORD[Q])
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
Human Resources and Social Development Canada (HRSDC)
Industry Canada
International Trade Ministry
Justice Canada (JC)
Members of the House of Commons
Minister of Health
National Defence (DND)
National Research Council (NRC)
Natural Resources Canada (NRCan)
Patented Medicine Prices Review Board (PMPRB)
Privy Council Office (PCO)
Public Works and Government Services Canada
Senate of Canada
Veterans Affairs Canada (VAC)
Western Economic Diversification Canada (WD)

In-house Corporation Details

Description of activities

Innovative pharmaceutical company (manufacturing, marketing and sales)

Responsible officer name and position during the period of this registration

Hugh O'Neill, President and CHief Executive Officer (CEO)

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
2150, blvd. St-Elzear West
Laval, QC H7L 4A8
Canada

Telephone number: 514-956-6246
Fax number: 514-339-5149

Parent Company Information

sanofi-aventis S.A.
- 174 avenue de France
  Paris 75013
  France

Subsidiary Beneficiary Information

sanofi-Pasteur Ltd.
- 1755 Steeles Avenue
  Toronto, ON M2R 3T4
  Canada

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Hugh O'Neill, President and CEO | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Sylvain Clermont, Director Public Policy | No public offices held
Myrtho-Emmanuelle Drouin, Manager, Public policy and Researched Based Pharmaceutical Companies Coordination | Public offices held
Kathy Megyery, Vice-president, Strategy and Public Affairs | No public offices held
Michel G. Tremblay, Associate Director, Federal Affairs | No public offices held

sanofi-aventis Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
sanofi-aventis Canada Inc.	2024-09-04	current
sanofi-aventis Canada Inc.	2008-07-29	2024-09-04

The following names have been used before July 2, 2008

sanofi-aventis Canada Inc.
sanofi-aventis

sanofi-aventis Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Stephanie Veyrun-Manetti	2022-02-25	Current
Carrie McElroy	2021-09-16	2022-02-25
Marissa Poole	2020-09-17	2021-09-16
Niven Al-Khoury	2015-09-01	2020-09-17
Jonathan Fairest	2012-05-15	2015-09-01
Hugh O'Neill	2009-07-01	2012-05-15
Jérôme Silvestre	2005-08-22	2009-07-01

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Special Assistant Parliamentary Affairs, Parliamentary Affairs	1997 to 1999	Not a designated office
Special Assistant, Parliamentary Affairs Prime Minister's Cabinet, Prime Minister's Cabinet	1994 to 1999	Not a designated office

Date Modified:: 2024-11-13

Search and menus

Language selection

Registration - In-house Corporation

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Registration Information

Associated Communications

Version 15 of 41 (2010-12-09 to 2011-01-13)

Version 15 of 41 (2010-12-09 to 2011-01-13)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties